Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy in Japanese Participants With Recurrent or Refractory Active Chronic Graft-Versus-Host Disease [Phase 3]

View source ↗

Summary

This report provides an update on a Phase 3 trial evaluating Axatilimab as monotherapy in Japanese participants with recurrent or refractory active chronic graf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Axatilimab (axatilimab)

Snippet

Sponsor: Incyte Biosciences Japan GK | Conditions: Chronic Graft-versus-host-disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING